Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) showed up in the 13F filings of 176 institutional investors as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 1,913,739 | 26.80% | $0.00 |
| FMR LLC | 31 Dec, 2025 | 0 | 5,139,212 | 45.16% | $0.00 |
| TCG Crossover Management, LLC | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -203,507 | -40.81% | $0.00 |
| PERCEPTIVE ADVISORS LLC | 31 Dec, 2025 | 0 | -667,483 | -7.46% | $0.00 |
| Commodore Capital LP | 31 Dec, 2025 | 0 | 1,574,522 | 38.63% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 517 | 10,340.00% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 531,162 | 10.07% | $0.00 |
| Saturn V Capital Management LP | 31 Dec, 2025 | 0 | -108,391 | -2.35% | $0.00 |
| Janus Henderson Group Plc | 31 Dec, 2025 | 0 | 1,929,639 | 76.08% | $0.00 |
| ADAR1 Capital Management, LLC | 31 Dec, 2025 | 0 | 914,510 | 105.58% | $0.00 |
| First Light Asset Management, LLC | 31 Dec, 2025 | 0 | -343 | -0.01% | $0.00 |
| Logos Global Management LP | 31 Dec, 2025 | 0 | -500,000 | -34.48% | $0.00 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 0 | 688,736 | 28.45% | $0.00 |
| Woodline Partners LP | 31 Dec, 2025 | 0 | 118 | 0.01% | $0.00 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 31 Dec, 2025 | 0 | -4,039,773 | -59.26% | $0.00 |
| Boxer Capital Management, LLC | 31 Dec, 2025 | 0 | -1,000,000 | -55.56% | $0.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 0 | 602,588 | 29.97% | $0.00 |
| STEMPOINT CAPITAL LP | 31 Dec, 2025 | 0 | 288,256 | 104.11% | $0.00 |
| Morgan Stanley | 31 Dec, 2025 | 0 | 409,523 | 21.00% | $0.00 |